FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship between HER2 and the transcription factor FoxM1 in breast cancer. HER2 and Fox...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Francis, Richard E., Myatt, Stephen S., Krol, Janna, Hartman, Johan, Peck, Barrie, McGovern, Ursula B., Wang, Jun, Guest, Stephanie K., Filipovic, Aleksandra, Gojis, Ondrej, Palmieri, Carlo, Peston, David, Shousha, Sami, Yu, Qunyan, Sicinski, Piotr, Coombes, R. Charles, Lam, Eric W.-F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065068/
https://ncbi.nlm.nih.gov/pubmed/19513552
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller